SureTrader SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs > Supernus Pharmaceuticals (SUPN)

1:21AM Supernus Pharma prices 10 mln share IP0

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 412
Posts 22,038
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Quarterly Report (10-q) "Edgar (US Regulatory)" - 1/20/2017 5:34:10 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 1/20/2017 5:31:06 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 1/20/2017 5:30:16 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 1/20/2017 5:29:23 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/17/2017 12:54:20 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/6/2017 4:44:43 PM
Supernus to Present at the 2017 J.P. Morgan Healthcare Conference "GlobeNewswire Inc." - 1/3/2017 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/15/2016 4:32:58 PM
Supernus Wins Appeal Case on Oxtellar XR® "GlobeNewswire Inc." - 12/12/2016 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/18/2016 4:17:22 PM
Supernus Receives Nasdaq Non-Compliance Notice "GlobeNewswire Inc." - 11/17/2016 4:30:00 PM
Supernus Provides Business Update "GlobeNewswire Inc." - 11/14/2016 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2016 6:16:43 AM
Supernus to Host a Business Update Call "GlobeNewswire Inc." - 11/11/2016 1:09:38 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/10/2016 4:51:45 PM
Supernus to Present at Three November Healthcare Conferences "GlobeNewswire Inc." - 11/7/2016 1:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/14/2016 4:17:33 PM
Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD "GlobeNewswire Inc." - 10/11/2016 7:45:00 AM
Supernus Schedules Conference Call to Present Results of Phase IIb Clinical Trial of SPN-812 in Children with ADHD "GlobeNewswire Inc." - 10/10/2016 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 10/7/2016 4:17:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/16/2016 5:11:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/24/2016 4:38:10 PM
Supernus Receives FDA Tentative Approval for Expanded Label of Trokendi XR® to Include Migraine Prophylaxis in Adults "GlobeNewswire Inc." - 8/19/2016 2:37:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/12/2016 4:32:53 PM
Supernus Announces Resignation of Dr. James Barrett from Board of Directors; Charles W. Newhall, III Elected Chairman "GlobeNewswire Inc." - 8/12/2016 4:15:00 PM
surf1944   Tuesday, 05/01/12 08:26:57 AM
Re: None
Post # of 124 
1:21AM Supernus Pharma prices 10 mln share IP0 at $5.00 per share, price in-line with expectations (SUPN) :

Supernus Pharmaceuticals (SUPN), a former Shire sub developing improved drug formulations for epilepsy and ADHD, plans to raise $55 million by offering 11.0 million shares at a price of $5.00. Supernus Pharmaceuticals will command a market value of $125 million. The Rockville, MD-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray (PJC) are the joint bookrunners on the deal.

http://seekingalpha.com/article/544941-6-ipos-planned-for-this-week?source=yahoo



surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist